
Denmark’s third-largest pharmaceutical company, Leo Pharma, might have some new owners to get used to.
The current owner, Leo Foundation, intends to sell parts of the firm’s shares, partially in order to finance the pharmaceutical company’s 2030 strategy.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app